Hyundai Bioscience’s antiviral for Dengue Fever to enter clinical trials in Brazil

“Aiming to offer a Dengue antiviral treatment course in $100 price range” Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ — Hyundai…